Albuquerque, New Mexico 87131


The purpose of this study is to determine if inhaled urea can be used to detect the presence of Pseudomonas Aeruginosa in the lungs

Study summary:

Dose Escalation study


Inclusion Criteria: - Patients with CF aged 18 years and above colonized with P. aeruginosa - Normal subjects ages 18 and above without CF or p. aeruginosa Exclusion Criteria: - for patients and volunteers will include the presence of asthma, allergic rhinitis, pregnancy, a history of gastric or duodenal ulcer, smoking, and a baseline FEV1 less than 60% of predicted normal value and a pulmonary exacerbation within the last 2 weeks as defined by use of systemic antibiotic



Primary Contact:

Principal Investigator
Hengameh Raissy, PharmD

Backup Contact:


Location Contact:

Albuquerque, New Mexico 87131
United States

Franceska Kelly, BS
Phone: 505-272-9889

Site Status: Recruiting

Data Source:

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.